Metabolon : Collaboration with the University of Texas Health Science Center at San Antonio

July 22, 2008 - Partnership to Accelerate Pre-Diabetes Diagnostic Development— Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, today announced that it is collaborating with Ralph A. DeFronzo, M.D. and colleagues at The University of Texas Health Science Center at San Antonio. The partnership will help drive development of Metabolon’s pre-diabetes diagnostic products as well as provide valuable data for insulin resistance and diabetes-related research...
... Metabolon will be analyzing samples from various studies conducted by Dr. DeFronzo’s team to discover and validate biochemical biomarkers reflective of insulin resistance and beta cell dysfunction. These markers will be used to help further develop Metabolon’s diagnostic tests in the area of insulin resistance, and how this relates to risk of developing metabolic diseases such as diabetes... Metabolon's Press Releases -

Metabolon and EGIR, Partnership to Accelerate Pre-Diabetes Diagnostic Development

March 18, 2008 - Metabolon, Inc., the leader in metabolomics-driven biomarker discovery and analysis, announced today a collaboration with the European Group for the Study of Insulin Resistance (EGIR). The EGIR has compiled large numbers of biological samples from studies conducted at 19 clinical research centers across Europe as part of their effort to understand insulin resistance and how it affects disease. Metabolon will discover and validate the biomarkers found in these samples that relate to insulin resistance. These markers will be used to help further develop Metabolon’s diagnostic test for pre-diabetic patients... Metabolon 's Press Release -